Background; There are two main types of Leishmaniasis; visceral Leishmaniasis (VL) and Tegumentary Leishmaniasis (TL). Again TL is classified into cutaneous Leishmaniasis (CL), and mucocutaneous Leishmaniasis (MCL). Cutaneous leishmaniasis (CL) is a serious public-health issue that can leave permanent scars or cause severe impairment. MCL can result in deformity with substantial aesthetic morbidity, social stigma, and psychological consequences. Because there are few precise clinical descriptions of CL in Ethiopia, a detailed description of the disease would be useful for early diagnosis. Objective; Describe the clinical pattern and treatment outcome of patients with Tegumentary Leishmaniasis in AAPH and TGSH in Bahir Dar, Ethiopia (2021-2022). Methods; A retrospective longitudinal study is undertaken using data from interviewer-administered questionnaires and chart review. TL cases were identified, patient files were collected, and the information was entered into an Epidata database before analyzed with SPSS version 25. Census is used and all TL patients who visited AAPH and TGSH between December 2021 and August 2022 are included in the study. Result: Between December 2021 and August 2020 we see a total of 103 patients. From this 58.3% (60/103) are LCL, 34% (35/103) are MCL and 7.8% (8/103) are DCL. From the total study 103 participants 87.4% of them had improvement from cutaneous leishmaniasis. The majority of respondents 29 (28.2%) and 27 (26.2%) had plaque and ulcerated lesion morphology, respectively. Conclusion and recommendation: Physicians should consider TL as a differential diagnosis in patients who have recently traveled to or have visited endemic areas due to the wide range of clinical manifestations of TL. In this study there is good outcome of the patients who had TL. Keywords; Cutaneous leishmaniasis, treatment outcome, TGSH, AAPH